Cargando…

Safety and Immunogenicity of a Single Dose of BNT162b2 COVID-19 mRNA Vaccine in a Warfarin-Treated Protein S Deficient Patient: A Case Report and Literature Review

Patients with protein S (PS) deficiency possibly have a higher risk of developing severe COVID-19 disease. Therefore, vaccination against SARS-CoV-2 infections is recommended for PS-deficient patients. However, there are limited data regarding the safety and immunogenicity of the currently available...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cucunawangsih, Cucunawangsih, Wijaya, Ratna Sari, Lugito, Nata Pratama Hardjo, Suriapranata, Ivet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779118/ https://www.ncbi.nlm.nih.gov/pubmed/36547235 http://dx.doi.org/10.3390/hematolrep14040051

Ejemplares similares

Antibody response after a third dose mRNA-1273 vaccine among vaccinated healthcare workers with two doses of inactivated SARS-CoV-2 vaccine
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

Antibody response to the inactivated SARS-CoV-2 vaccine among healthcare workers, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Co-Occurrence of SARS-CoV-2 Infection and Inactivated SARS-CoV-2 Vaccination among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Post-vaccination cases of COVID-19 among healthcare workers at Siloam Teaching Hospital, Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Recurrence of Asymptomatic COVID-19 after Recovery among Healthcare Workers
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2022)

REACTOGENICITY OF HETEROLOGOUS MRNA-BASED COVID-19 VACCINE BOOSTER IN YOUNG ADULTS IN INDONESIA- A SHORT COMMUNICATION.
por: Neneng, SURYADINATA, et al.
Publicado: (2023)

How Does Mucorales Benefit from the Dysregulated Iron Homeostasis During SARS-CoV-2 Infection?
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2021)

Antimicrobial Resistance of Salmonella enterica Serovars Typhi and Paratyphi Isolates from a General Hospital in Karawaci, Tangerang, Indonesia: A Five-Year Review
por: Hardjo Lugito, Nata Pratama, et al.
Publicado: (2017)

Trends of Dengue Disease Epidemiology
por: Cucunawangsih,, et al.
Publicado: (2017)

A Lethal Case of Sphingomonas paucimobilis Bacteremia in an Immunocompromised Patient
por: Hardjo Lugito, Nata Pratama, et al.
Publicado: (2016)

Immunoglobulin G (IgG) to IgM ratio in secondary adult dengue infection using samples from early days of symptoms onset
por: Cucunawangsih, et al.
Publicado: (2015)

Is procalcitonin a part of human immunological response to SARS-CoV-2 infection or “just” a marker of bacterial coinfection?
por: Lugito, Nata Pratama Hardjo
Publicado: (2021)

The dilemma in a case of immune thrombocytopenia in a patient with human immunodeficiency virus on antituberculosis treatment for miliary pulmonary tuberculosis
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2019)

Hydronephrosis as an Unusual Cause of Acute Pancreatitis
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2015)

Social media exposure and mental health problems during coronavirus disease 2019 pandemic in Indonesia
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2021)

Immune-Mediated Adverse Drug Reactions (IM-ARDs) in the Form of Drug-Induced Immune Thrombocytopenia and Cutaneous Adverse Drug Reactions (CARD) Due to Clindamycin in an Human Immunodeficieny Virus (HIV) Patient
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2023)

Resident Medical Officer's Knowledge of Sepsis: A Qualitative Study
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2015)

Nightmare and Abnormal Dreams: Rare Side Effects of Metformin?
por: Yanto, Theo Audi, et al.
Publicado: (2018)

Mental health problems in Indonesian internship doctors during the COVID-19 pandemic
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2021)

Prognostic value of inflammatory markers in patients with COVID-19 in Indonesia
por: Prasetya, Ignatius Bima, et al.
Publicado: (2021)

Essential thrombocythemia, hemolytic anemia and hepatic cirrhosis: Could there be an association?
por: Lugito, Nata Pratama Hardjo, et al.
Publicado: (2018)

Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
por: Payne, Rebecca P., et al.
Publicado: (2021)

Extensive drug resistant (XDR) Acinetobacter baumannii parappendicular-related infection in a hydrocephalus patient with ventriculoperitoneal shunt: a case report
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2020)

Diabetic Foot Gangrene Patient with Multi-drug Resistant Pseudomonas Putida Infection in Karawaci District, Indonesia
por: Hardjo Lugito, Nata Pratama, et al.
Publicado: (2015)

A High Distribution of Resistant Pathogens among Critically Ill Neonates from Secondary Referral Hospital of Indonesia
por: Cucunawangsih, Cucunawangsih, et al.
Publicado: (2021)

Prevalence and Determinants of COVID-19 Vaccine Acceptance in South East Asia: A Systematic Review and Meta-Analysis of 1,166,275 Respondents
por: Yanto, Theo Audi, et al.
Publicado: (2022)

Coronavirus disease 2019 and cardiovascular system: A narrative review
por: Kwenandar, Felix, et al.
Publicado: (2020)

Genetic factors associated with patient-specific warfarin dose in ethnic Indonesians
por: Suriapranata, Ivet M, et al.
Publicado: (2011)

Immunogenicity of BNT162b2 mRNA COVID-19 Vaccine in Patients with Cardiovascular Disease
por: Naruse, Hiroyuki, et al.
Publicado: (2021)

Reduced immunogenicity of the mRNA vaccine BNT162b2 in patients with idiopathic pulmonary fibrosis
por: Karampitsakos, Theodoros, et al.
Publicado: (2022)

Skin Damage and Quality of Life among Healthcare Workers Providing Care during the COVID-19 Pandemic: A Multicenter Survey in Banten Province, Indonesia
por: Christopher, Paulus M., et al.
Publicado: (2022)

ANTIMICROBIAL RESISTANCE AND MORTALITY
por: Hariyanto, Hori, et al.
Publicado: (2022)

Experience of using tocilizumab for treatment in Indonesian patients with severe COVID-19
por: Widysanto, Allen, et al.
Publicado: (2021)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: A systematic review and meta-analysis
por: Hariyanto, Timotius Ivan, et al.
Publicado: (2021)

Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds
por: Simões, Eric A F, et al.
Publicado: (2023)

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
por: Levy, Itzchak, et al.
Publicado: (2021)

Comparative Immunogenicity of BNT162b2 mRNA Vaccine with Natural SARS-CoV-2 Infection
por: Psichogiou, Mina, et al.
Publicado: (2021)

The Safety and Immunogenicity of the mRNA-BNT162b2 SARS-CoV-2 Vaccine in Hemodialysis Patients
por: Zitt, Emanuel, et al.
Publicado: (2021)

Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients
por: Pri-Paz Basson, Yael, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7hksn522lf075q26ubb398lq22